Phillips-Medisize to expand manufacturing facility in Denmark

Published: 10-Jan-2020

The existing 8,400 sqm building in Struer will be repurposed for new cleanroom

Phillips-Medisize, a Molex company, announced expansion of its current Global Innovation and Development (GID) site in Struer, Denmark with a dedicated Manufacturing Development and Clinical build unit, which is scheduled to open in the second quarter of 2020.

As a recognised global leader, Phillips-Medisize provides a wide range of custom drug delivery devices, connected health solutions and end-to-end manufacturing services worldwide.

The Phillips-Medisize manufacturing facility will be equipped to serve clients with agile set up for cleanroom assembly and moulding (e.g. for clinical trials).

Approximately 500 sqm of floor space from the existing 8,400 sqm building will be repurposed for the cleanroom.

The facility is designed to support late-stage development of medium- and high-volume products and processes, under GMP and using state-of-the-art equipment.

“This expansion accelerates the manufacture of innovative, compliant and best-in-class products while reducing time to market and lowering launch risk for drug delivery device customers,” said John Horgan, Vice President, Global Sales and Marketing of Phillips-Medisize. “Furthermore, it strengthens our client focus in Scandinavia by complementing the activities of our existing GID in Struer and our newest GID in Copenhagen.”

You may also like